Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 157 (ZNF157) is a member of the zinc finger protein family, characterized by the presence of multiple C2H2-type zinc finger domains and KRAB (Krüppel-associated box) domains, which typically mediate transcriptional repression[3][4][7]. ZNF157 is thought to act as a DNA-binding transcription factor, regulating gene expression via chromatin interactions, though its specific physiological targets and regulatory roles remain incompletely characterized[3][5][7]. It is encoded by a gene on chromosome Xp11.23 and is predicted to function primarily in regulating DNA-templated transcription, potentially influencing lineage balance during development[2]. There is currently no evidence that ZNF157 is a direct therapeutic target, and no known drugs are reported to interact with it. While ZNF157 is associated with certain Mendelian developmental disorders, its broader biological and clinical significance in common diseases and targetable pathways is not well established[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 157 (ZNF157).